TW217417B - - Google Patents
Info
- Publication number
- TW217417B TW217417B TW081109457A TW81109457A TW217417B TW 217417 B TW217417 B TW 217417B TW 081109457 A TW081109457 A TW 081109457A TW 81109457 A TW81109457 A TW 81109457A TW 217417 B TW217417 B TW 217417B
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- lower alkyl
- formula
- alkyl group
- atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34767091 | 1991-12-04 | ||
JP35373891 | 1991-12-18 | ||
JP23420792 | 1992-08-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW217417B true TW217417B (zh) | 1993-12-11 |
Family
ID=27332096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW081109457A TW217417B (zh) | 1991-12-04 | 1992-11-25 |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0555537B1 (zh) |
AT (1) | ATE197305T1 (zh) |
AU (1) | AU657585B2 (zh) |
CA (1) | CA2084163C (zh) |
DE (1) | DE69231546T2 (zh) |
TW (1) | TW217417B (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2121724A1 (en) | 1993-04-21 | 1994-10-22 | Toshifumi Watanabe | Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction |
CA2135151A1 (en) * | 1993-11-08 | 1995-05-09 | Mitsuhiro Wakimasu | Cyclic hexapeptides, their production and use |
US5863902A (en) * | 1995-01-06 | 1999-01-26 | Sibia Neurosciences, Inc. | Methods of treating neurodegenerative disorders using protease inhibitors |
WO1996033170A1 (en) * | 1995-04-21 | 1996-10-24 | Novarits Ag | N-aroylamino acid amides as endothelin inhibitors |
EP0852584A1 (en) * | 1995-09-26 | 1998-07-15 | Takeda Chemical Industries, Ltd. | Peptide derivatives having endothelin receptor antagonistic activity |
US7115664B2 (en) * | 2000-03-16 | 2006-10-03 | Sepracor Inc. | Peptidomimetic ligands for cellular receptors and ion channels |
DE10105077A1 (de) * | 2001-02-05 | 2002-08-08 | Febit Ferrarius Biotech Gmbh | Hybrid-Schutzgruppe |
EP1243262B1 (en) | 2001-03-20 | 2006-05-31 | Schwarz Pharma Ag | Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain |
EP1243263B1 (en) | 2001-03-21 | 2002-11-27 | Schwarz Pharma Ag | Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
AU2004294714B2 (en) | 2003-12-02 | 2009-12-10 | Ucb Pharma Gmbh | Novel use of peptide compounds for treating central neuropathic pain |
MXPA06011937A (es) | 2004-04-16 | 2007-01-26 | Sanol Arznei Schwarz Gmbh | Uso de compuestos peptidicos para la profilaxis y el tratamiento de dolor de cabeza cronico. |
EP1604655A1 (en) | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating pain in trigeminal neuralgia |
BRPI0514721A (pt) | 2004-08-27 | 2008-06-24 | Sanol Arznei Schwarz Gmbh | uso de compostos de peptìdeos para tratar dor de cáncer ósseo, dor induzida por quimioterapia e nucleosìdeo |
SI2462990T1 (sl) | 2006-06-15 | 2014-04-30 | Ucb Pharma Gmbh | Farmacevtski sestavek, ki obsega lakozamid in levetiracetam, s sinergističnim antikonvulzivnim učinkom |
WO2017024032A2 (en) | 2015-08-03 | 2017-02-09 | Enb Therapeutics, Llc | Compositions and methods for treating cancers associated with etbr activation |
GB201712282D0 (en) * | 2017-07-31 | 2017-09-13 | Nodthera Ltd | Selective inhibitors of NLRP3 inflammasome |
EP4089102A1 (en) * | 2021-05-14 | 2022-11-16 | Insusense ApS | Modulators of sortilin activity |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5284828A (en) * | 1990-05-14 | 1994-02-08 | Fujisawa Pharmaceutical Co. Ltd. | Peptide compound and its preparation |
CA2043741C (en) * | 1990-06-07 | 2003-04-01 | Kiyofumi Ishikawa | Endothelin antagonistic peptide derivatives |
GB9123967D0 (en) * | 1991-11-12 | 1992-01-02 | Fujisawa Pharmaceutical Co | New compound and its preparation |
-
1992
- 1992-11-25 TW TW081109457A patent/TW217417B/zh not_active IP Right Cessation
- 1992-11-26 EP EP92120225A patent/EP0555537B1/en not_active Expired - Lifetime
- 1992-11-26 DE DE69231546T patent/DE69231546T2/de not_active Expired - Lifetime
- 1992-11-26 AT AT92120225T patent/ATE197305T1/de not_active IP Right Cessation
- 1992-11-30 CA CA002084163A patent/CA2084163C/en not_active Expired - Lifetime
- 1992-12-02 AU AU29838/92A patent/AU657585B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
EP0555537A2 (en) | 1993-08-18 |
CA2084163A1 (en) | 1993-06-05 |
EP0555537B1 (en) | 2000-11-02 |
EP0555537A3 (en) | 1994-11-02 |
DE69231546D1 (de) | 2000-12-07 |
DE69231546T2 (de) | 2001-05-31 |
AU2983892A (en) | 1993-06-10 |
CA2084163C (en) | 2004-06-29 |
AU657585B2 (en) | 1995-03-16 |
ATE197305T1 (de) | 2000-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW217417B (zh) | ||
DE69130408D1 (de) | Endothelinantagonistische Peptidderivate | |
DE122008000051I1 (de) | 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel | |
ATE236890T1 (de) | Sauerstoff oder schwefel enthaltende 5-gliedrige heteroaromatishe derivative als factor xa hemmer | |
KR940005617A (ko) | 안지오텐신 ii길항 물질 | |
RS49921B (sr) | Terapeutski biaril derivati | |
CA2238410A1 (en) | Novel indole-2,3-dione-3-oxime derivatives | |
ES2126075T3 (es) | Derivados biciclicos nitrogenados como inhibidores de la propil-endopeptidasa. | |
WO2002048122A3 (en) | Benzamidine derivatives | |
CA2081891A1 (en) | Quinolizinone type compounds | |
BG105373A (en) | 2-phenylpyran-4-one derivatives | |
ATE248598T1 (de) | Inhibitoren der kainsäure-neurotoxizität sowie pyridothiazinderivate | |
DE69230415D1 (de) | Cephalosporinverbindungen und ihre pharmazeutische Präparate | |
NZ309499A (en) | Styryl benzimidazole derivatives useful as inhibitors of smooth muscle cell proliferation | |
ES2170804T3 (es) | Derivados de dihidro-2,3-benzodiazepina. | |
PT728748E (pt) | Novos derivados da benzodiazepina | |
DE69334353D1 (de) | Benzodiazepin-Derivate, verwendbar als CCK-Rezeptor Antagonisten | |
AU532634B2 (en) | Thiazolyl derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4A | Expiration of patent term of an invention patent |